Being familiar with the risk factors that predispose a patient to cord prolapse is the first step toward preventing the complication. Recognizing the early warning signs is the first step toward averting a life-threatening disaster.
Who's at risk?
Multiparous patients are 60% more likely to experience umbilical cord prolapse.5 The presenting fetal part is less likely to be engaged at the onset of labor in a multiparous patient and if the membranes do rupture, it can allow the umbilical cord to pass beyond the unengaged presenting part. Multiple gestations delivering vaginally are also at risk but that risk is greater for the second twin because of a greater likelihood of malpresentation for the second twin.1,6,7 Murphy and associates showed that delivery at less than 37 weeks is independent of birth weight as a risk factor for umbilical cord prolapse.7 Polyhydramnios is yet another independent risk factor for cord prolapse, as it is frequently associated with unstable lie.8 Subsequent membrane rupture, whether spontaneous or artificial, can result in a fluid gush that inadvertently forces the cord to pass beyond the presenting part.
Which obstetrical interventions pose a danger?
Obstetrical interventions that involve manipulation or elevation of the presenting fetal part can predispose to cord prolapse by allowing the cord to pass alongside the presenting part and result in either overt or occult prolapse. Interventions that increase the likelihood of cord prolapse include artificial rupture of membranes, internal scalp electrode application, intrauterine pressure catheter placement, forceps or vacuum application, manual rotation of the fetal head, amnioinfusion, and external cephalic version.3,9 Keep in mind, however, that some of the evidence to "indict" these obstetric interventions has been challenged.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More
Importance of reproductive health services for adolescents during the COVID-19 pandemic
October 30th 2024In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.
Read More